RAF1 and hypertrophic cardiomyopathy: Differences in clinical severity also reflect the hierarchical positioning of proteins within the pathway; for instance, RAF1 variants preferentially activate cardiac-specific signaling pathways, explaining the high prevalence of hypertrophic cardiomyopathy [32].